About Kristina Whitfield

This author has not yet filled in any details.
So far Kristina Whitfield has created 14 blog entries.
16 04, 2019

Vertebrate Antibodies Joins Forces with Forsage Holdings Ltd

2019-04-16T14:28:33+00:00April 16th, 2019|News|

March 2019- Joining forces with Forsage Holdings Ltd VERTEBRATE ANTIBODIES LTD (VAL) is delighted to announce a Strategic Alliance with Forsage Holdings Ltd (FH) Forsage Holdings Ltd is a dynamic and growth focused Irish family owned private Investment Company with investments in established and fast evolving [...]

8 04, 2019

Vertebrate Antibodies & Marinnovac Collaboration

2019-04-16T14:23:58+00:00April 8th, 2019|News|

Animal Pharm: The Vertebrate Antibodies and Marinnovac Collaboration The new firm is based in O Porriño, Spain. It is aiming to fast-track fish and shrimp disease prevention strategies through collaborations. The firm's focus is on autogenous, experimental and licensed vaccines, as well as diagnostic services. The [...]

28 03, 2019

Grants and Announcements

2019-04-05T10:20:42+00:00March 28th, 2019|News|

A Timeline of Our Grants and Announcements May 2017 - ISCF Agri-food technology catalyst seeding catalyst award Vertebrate Antibodies in collaboration with Professor Sam Martin at Aberdeen University have secured a BBSRC SEEDING CATALYST AWARD to support a project on developing [...]

8 03, 2019

Vertebrate Antibodies – Publications

2019-03-21T13:03:12+00:00March 8th, 2019|News|

Vertebrate Antibodies - Publications Alnabulsi A, Cash B, Hu Y, Silina L, Alnabulsi A, Murray GI (2019). The expression of brown fat associated proteins in colorectal cancer and the relationship of uncoupling protein 1 with prognosis. Int J Cancer. PMID: 30737786. DOI: 10.1002/ijc.32198. Veenstra KA, Alnabulsi [...]

4 01, 2018

April 2017 – A landmark milestone

2018-08-01T14:20:33+00:00January 4th, 2018|News|

VAL products catalogue has passed the 150 mark. The antibodies are towards key targets within a wide range of organisms for research and clinical applications, all of which are currently available for licensing from Cancer Research Technology at their Ximbio site (https://ximbio.com/organisation/48/vertebrate-antibodies-limited).

4 01, 2018

March 2016 – Development of monoclonal antibodies to monitor animal’s health as part of European project

2018-08-01T14:24:31+00:00January 4th, 2018|News|

VetBioNet is a European project funded under a call from Horizon 2020 for funding large research infrastructures. VetBioNet (http://www.vetbionet.eu/) overarching goal is to establish and maintain a comprehensive network of pre-eminent high-containment (BSL3) research facilities, academic institutes, international organisations and industry partners that is dedicated to advance research [...]

21 10, 2016

April 2015

2018-08-01T14:25:34+00:00October 21st, 2016|News|

April 2015 – Development of monoclonal antibodies for parasite-specific molecules In April 2015 a European Union Horizon 2020 Project funded to support the prospective fish-farming industry has started. ParaFishControl (www.parafishcontrol.eu) overarching goal is to increase the sustainability and competitiveness of the European aquaculture industry by improving our understanding [...]

13 11, 2014

October 2014

2018-08-01T14:26:15+00:00November 13th, 2014|News|

VAL new antibodies towards key zebrafish targets: The antibodies are specific to zebrafish targets involved in key biological pathways including immunity, angiogenesis, tumour suppressors and drug metabolisers. The list are as follows; CD4, FOXP3, IFNγ(1), p53, MMP9, AKT1, FLT1, FGF1, TIMP2a, PXR and CYP3C1. Datasheets available on the [...]

13 11, 2014

June 2014

2018-08-01T14:26:35+00:00November 13th, 2014|News|

VAL new antibodies towards key immune targets in salmonids: In recent years, aquaculture has expanded significantly and become a major economic sector. In the last two decades, commercial vaccines have become available through research to prevent infectious diseases caused by some pathogens. However there is still a long [...]

Go to Top